Myocardial infarction: When and how should we initiate treatment with ace inhibitors

Cardiology (Switzerland)

Volumn 87, Issue , 1996, Pages 16-22

  Latini, Roberto ^a   Maggioni, Aldo P ^a   Zuanetti, Giitlio ^a  

^a ANMCO RESEARCH CENTER   (Italy)

Author keywords

Angiotensin converting enzyme; Clinical trials; Myocardial infarction

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LISINOPRIL;

ACUTE HEART INFARCTION; CLINICAL TRIAL; CONFERENCE PAPER; CONGESTIVE HEART FAILURE; DRUG SAFETY; HEART HEMODYNAMICS; HEART INFARCTION; HEART LEFT VENTRICLE FAILURE; HUMAN; MORTALITY; PRIORITY JOURNAL;

ADULT; AGED; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CLINICAL TRIALS; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROGNOSIS; RISK FACTORS; SURVIVAL RATE; VENTRICULAR DYSFUNCTION, LEFT;

EID: 13344278676     PISSN: 00086312     EISSN: 14219751     Source Type: Journal    
DOI: 10.1159/000177163     Document Type: Article

References (22)

1. G1SS1-2: A factorial randomized trial of alte-plase versus streptokinase and heparin versus no heparin among 12.490 patients with acute myocardial infarction. Lancet 1990:336:65-71.
2. The CONSENSUS Trial Group: Effects of en-alapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). N Engl J Med 1987;316:1429-1435.
3. Cohn JN. Johnson G. Zicsche S. Cobb F. Francis G, Tristani F, Smith R, Dunkman B, Loeb H, Wong M. Bhat G, Goldman S. Fletcher RD. Doherty J, Hughes CV, Carson P. Cintron G. Shabetai R, Haakenson C: A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. N Engl J Med 1991;325:303-310.
4. The SOLVD Investigators: Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 1991;325:293-302.
5. The SOLVD Investigators: Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. N Engl J Med 1992;327:685-691.
6. Sharpe N, Smith H. Murphy J. Greaves S. Hart H, Gamble G: Early prevention of left ventricular dysfunction after myocardial infarction with angiotensin-converting enzyme inhibition. Lancet 1991;337:872-876.
7. Pfeffer MA, Lamas GA, Vaughan DE, Parisi AF, Braunwald E: Effect of captopril on progressive ventricular dilatation after anterior myocardial infarction. N Engl J Med 1988:319; 80-86.
8. Sharpe N, Murphy J, Smith H, Hannan S: Treatment of patients with symptomless left ventricular dysfunction after myocardial infarction. Lancet 1988;i:255-259.
9. Ertl G. Kloner RA, Alexander RW, Braunwald E: Limitation of experimental infarct size by an angiotensin-converting enzyme inhibitor. Circulation 1982:65:40-48.
10. Magrini F, Reggiani P. Roberts N, Meazza R. Ciulla M. Zanchetti A: Effects of angiotensin and angiotensin blockade on coronary circulation and coronary reserve. Am J Med 1988,84 (suppl 3A):55-60.
11. McAlpine HM, Morton JJ, Leckic B, Rumley A, Gillen G, Dargie HJ: Neuroendocrine activation after acute myocardial infarction. Br Heart J 1988;60:117-124.
12. Pfeffer MA. Braunwald E. Moye LA, Basta L, Brown EJ. Cuddy TE, Davis BR. Geltman EM, Goldman S, Fiaker GC. Klein M. Lamas GA. Packer M, Rouleau J, Rouleau JL. Rutherford J. Wertheimer JH, Hawkins CM, on behalf of the SAVE Investigators: Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. N Engl.1 Med 1992:327: 669-677.
13. The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators: Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. Lancet 1993:342:821-828.
14. The TRACE Study Group: The Trandolapril Cardiac Evaluation (TRACE) study: Rationale, design, and baseline characteristics of the screened population. Am J Cardiol 1994:73: 44C-50C.
15. Van Gilst WH, De Graeff PA, Wesseling H, de Langen CDJ: Reduction of reperfusion arrhythmias in the ischemic isolated rat heart by angiotensin converting enzyme inhibitors: A comparison of captopril, enalapril. and HOE 498. J Cardiovasc Pharmacol 1986;8:722-728.
16. Swedberg K. Held P. Kjekshus J. Rasmussen K. Ryden L. Wedel H. CONSENSUS II Study Group: Effects of the early administration of enalapril on mortality in patients with acute myocardial infarction. N Engl J Med 1992:327: 678-684.
17. Groppo Italiano per lo Studio della Sopravvi-venza ncll'lnfarto Miocardico. GISSI-3: Effects of lisinopril and transdermal glyceryl trinitrate singly and together on 6-weck mortality and ventricular function after acute myocardial infarction. Lancet 1994:343:1115-1122.
18. ISIS-4 Collaborative Group. ISIS-4: A randomised factorial trial assessing early oral captopril. oral mononitrate, and intravenous magnesium sulphate in 58050 patients with suspected acute myocardial infarction. Lancet 1995:345: 669-685.
19. Chinese Cardiac Study Collaborative Group: Oral captopril versus placebo among 13634 patients with suspected acute myocardial infarction: Interim report from the Chinese Cardiac Study (CCS-1). Lancet 1995:345:686-687.
20. Tognoni G, Franzosi MG. Latini R. Maggioni AP, Zuanctti G. GISSI-3 Investigators: Letter. Lancet 1995;345:1373-1374.
21. Ambrosioni E. Borghi C. Magnani B. for the Survival of Myocardial Infarction Long-term Evaluation (SMILE) Study Investigators. The effect of the angiotensin-converting-enzyme inhibitor zofenopril on mortality and morbidity after anterior myocardial infarction. N Engl J Med 1995:332:80-85.
22. Latini R, Maggioni AP. Flather M, Sleight P. Tognoni G, et al: ACE-inhibitor use in patients with myocardial infarction. Summary of evidence from clinical trials. Circulation 1995:92: 3 1 32-3 1 37.